Eurofins-Cerep SA

Paris Stock Exchange ALECR.PA

Eurofins-Cerep SA Market Capitalization on January 13, 2025: USD 101.28 M

Eurofins-Cerep SA Market Capitalization is USD 101.28 M on January 13, 2025, a -19.34% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Eurofins-Cerep SA 52-week high Market Capitalization is USD 130.47 M on June 05, 2024, which is 28.83% above the current Market Capitalization.
  • Eurofins-Cerep SA 52-week low Market Capitalization is USD 95.39 M on December 24, 2024, which is -5.81% below the current Market Capitalization.
  • Eurofins-Cerep SA average Market Capitalization for the last 52 weeks is USD 112.52 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Paris Stock Exchange: ALECR.PA

Eurofins-Cerep SA

CEO Mr. Damien Vielliard
IPO Date April 12, 2000
Location France
Headquarters Le Bois l'Evêque
Employees 209
Sector Health Care
Industries
Pharmaceuticals Biotechnology Research & Consulting
Description

Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.

StockViz Staff

January 15, 2025

Any question? Send us an email